Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02852226 · ClinicalTrials.gov registry record · NA

CRUSH-PrEP for Women Project

A NA study of HIV and Sexually Transmitted Diseases, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT02852226 is a NA study of HIV and Sexually Transmitted Diseases that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02852226, a NA study of HIV and Sexually Transmitted Diseases, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

UCSF is conducting an evaluation of a demonstration project. The aims of the CRUSH-PrEP for Women project are to integrate the delivery of a comprehensive PrEP package for HIV-negative at-risk women into primary care settings. The delivery of the PrEP package will leverage the well regarded reputation of the LifeLong primary care clinicians to provide a highly effective combination HIV prevention strategy including; PrEP, post-exposure prophylaxis (nPEP), repeat HIV and STI testing, treatment of sexually transmitted infections. Counselling for for sexual health promotion and services specifically designed for vulnerable women such as staying free of violence and domestic abuse will be offered as an integrated part of this package. UCSF will conduct evaluation activities only. The investigators expect that UCSF will enroll 50 participants in the evaluation assessments across the 15 months of data collection. Evaluation cohort participants will provide quantitative data to evaluate the linkage and engagement in care among clinic attendees as well as the uptake and use of Pre-Exposure Prophylaxis.

Interventions

  • OTHER Pre Exposure Prophylaxis
  • BEHAVIORAL Characteristics of women who enroll
  • BEHAVIORAL referral sources of women who enroll

Study Locations (1)

California

  • Lifelong Medical Care - Oakland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-05
Est. Completion 2017-08
Phase NA

What the Registry Record Tells You About NCT02852226

The ClinicalTrials.gov registry entry for NCT02852226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 3 interventions - of which Pre Exposure Prophylaxis is the first listed.

NCT02852226 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02852226 about?

NCT02852226 is a clinical study titled "CRUSH-PrEP for Women Project". UCSF is conducting an evaluation of a demonstration project. The aims of the CRUSH-PrEP for Women project are to integrate the delivery of a comprehensive PrEP package for HIV-negative at-risk women into primary care settings. The delivery of the PrEP package will leverage the well regarded reputati...

What is the current status of trial NCT02852226?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-05. Estimated completion is 2017-08.

What conditions does trial NCT02852226 study?

This clinical trial studies the following conditions: HIV, Sexually Transmitted Diseases.

What interventions are being tested in trial NCT02852226?

The interventions under investigation include: Pre Exposure Prophylaxis (OTHER), Characteristics of women who enroll (BEHAVIORAL), referral sources of women who enroll (BEHAVIORAL).

Who is sponsoring clinical trial NCT02852226?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02852226 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.